News
The stock's fall snapped a four-day winning streak.
7d
Zacks Investment Research on MSNCVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...
Health care stocks are tanking in Wednesday's extended trading after CMS announced a significant expansion of its auditing ...
CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...
Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year ...
CVS’s stock surges toward a one-year high after profit and revenue beat expectations, amid strength in the pharmacy business, ...
On May 19, Guy P Sansone, Board Member at CVS Health CVS +0.19% Get Free Report executed a significant insider buy, as disclosed in the latest SEC filing.
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.
In terms of valuation, CVS Health’s forward 12-month price-to-earnings (P/E) is 9.46X, a discount to the S&P 500’s 21.37X. Image Source: Zacks Investment Research However, the stock is trading ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results